Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-02-28 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于召开2018年度股东大会的通知公告（更新后）
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2018 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司, including the meeting date, voting procedures, agenda items, and instructions for shareholders. It includes information about the election of board members, reports to be presented, and voting methods. The document does not contain actual financial statements or results but rather the announcement and procedural details for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (8194 characters) supports it being a full notice rather than a brief announcement or a report publication announcement.
2019-02-28 Chinese
关于举行2018年度报告网上说明会的公告（更新后）
Investor Presentation Classification · 90% confidence The document is an announcement about holding an online explanation meeting for the 2018 Annual Report of the company 嘉事堂药业股份有限公司. It mentions the approval and publication of the 2018 Annual Report and invites investors to participate in the online performance explanation meeting. The document itself does not contain the full annual report or detailed financial data but rather announces the event related to the annual report. The document length is short (636 characters), and it serves as a notice for an investor presentation related to the annual report. Therefore, the best classification is Investor Presentation (IP).
2019-02-28 Chinese
关于召开2018年度股东大会通知及网上说明会通知补充更正公告
AGM Information Classification · 95% confidence The document is a notice regarding the correction of a previously announced Annual General Meeting (AGM) notice and an online explanation meeting related to the 2018 fiscal year. It includes detailed information about the agenda items for the AGM, specifically the election of board members and supervisors, voting procedures, and the announcement of an online performance explanation meeting. The document does not contain financial statements or detailed financial analysis but focuses on the meeting logistics, agenda, and voting details. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related notices. The document is over 5,000 characters and is not merely an announcement of a report publication but a substantive correction and update to the AGM notice and related meeting information.
2019-02-28 Chinese
独立董事关于第五届董事会第三十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters related to the fifth board meeting of Jia Shi Tang Pharmaceutical Co., Ltd. It includes independent opinions on the 2018 audit report, internal control self-evaluation report, related party transactions, fundraising usage, profit distribution plan, accounting policy changes, board election nominations, and senior management changes. The document is a formal statement by independent directors expressing their views on these matters, which is typical of board/management information disclosures. It is not the audit report itself, nor a full annual report, but rather an official board-related opinion document. The presence of management changes and board election opinions further supports classification as Board/Management Information (MANG). The document length is under 5,000 characters, but it contains substantive content rather than just an announcement of a report publication, so it is not RPA or RNS. Therefore, the best fit is MANG.
2019-02-27 Chinese
关于职工代表监事选举结果的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election results of employee representative supervisors for the company's supervisory board. It includes details about the elected individuals, their qualifications, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting presentation or voting results from a shareholder meeting. The content is focused on management/board composition changes specifically related to supervisory board members. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2019-02-27 Chinese
第五届董事会第三十次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 30th meeting of the 5th Board of Directors of 嘉事堂药业股份有限公司, held on February 26, 2019. It includes approvals of various reports such as the 2018 Board Work Report, 2018 Financial Statements, Profit Distribution Plan, Social Responsibility Report, and other governance matters. The document repeatedly states that these reports are available elsewhere (e.g., on the 巨潮资讯网 website) and that these reports require shareholder approval at the upcoming Annual General Meeting. The document also includes announcements of board member nominations and management changes, all requiring shareholder approval. The document is essentially a formal board meeting resolution announcement summarizing decisions and referring to full reports published separately. It does not contain the full annual report or detailed financial statements itself but rather the board's approvals and notices about these reports and proposals. Therefore, this document is best classified as Board/Management Information (MANG) because it primarily announces board meeting resolutions, including management and board changes, and approvals of reports to be submitted to shareholders, rather than the reports themselves or their publication announcements.
2019-02-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.